We examined sequential serum samples from 12 patients with well-characterized posttransfusion non-A, non-B hepatitis who had an acute, resolving self-limited type of clinical course for the presence of antibody to the hepatitis C virus nucleocapsid (core) protein (p22) expressed by a recombinant bac
Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease
โ Scribed by Jun Hayashi; Koya Nakashima; Yasuhiro Kishihara; Misako Ohmiya; Eriko Yoshimura; Miki Hirata; Seizaburo Kashiwagi
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 528 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0163-4453
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
To study the role of hepatitis C virus in non-A, non-B chronic hepatitis, 49 liver biopsy samples from 40 patients with non-A, non-B chronic hepatitis and 9 control patients were analyzed by complementary DNA/polymerase chain reaction. Two segments of the HCV genome, one in the nonstructural region
The relationship between plasma hepatitis C virus (HCV) RNA levels, antibody positivity, and hepatocellular damage were studied i n 41 patients with non-A, non-B chronic liver disease. The patients were placed into t w o groups according to the plasma levels of HCV-RNA: plasma HCV-RNA level was esti
Localization of hepatitis C virus (HCV) RNA was investigated by non-radioactive in situ hybridization in human liver specimens of chronic non-A, non-B (NANB) hepatitis patients who were seropositive for antibodies to HCV (anti-HCV). For in situ hybridization, T-T dimerized synthetic oligodeoxynucleo
In a retrospective study, antibody to hepatitis C virus (anti-HCV antibody) was measured in 80 patients with acute viral hepatitis (type A, 18; type B, 21; type non-A,non-B, 41). Anti-HCV antibody was found in 12 of 20 patients (60%) with non-A,non-B post-transfusion hepatitis (NANB-PTH) and in 9 of